Why the market is tanking and what are we doing?
Next Investors Jun 11, 2022
Many small cap stocks (including our Portfolio stocks) have taken a downward hit on relatively small volume in June. And to put the boot into an already rougher than usual “sell in May and go away” and “tax loss selling June”...
We are Rolling the Dice on this One…
Next Investors Oct 13, 2020
Long term Creso Pharma (ASX: CPH) shareholders have had a rough ride in the last 12 months. Last week the $20M capped CPH raised circa A$9M at $0.0291 per share, finally extinguishing the company’s debt and ridding the company of major con note holders that were hampering any share price appreciation.
Will the dust settle on the stock market?
Finfeed Archived Feb 28, 2020
Companies have not changed their earnings forecast, which means they do not foresee any issues arising from the coronavirus. Given this, I see no reason to sell, as many of these companies will bounce back in the not too distant future.